HCPCS codes / M / M0244
M0244
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency
- Code type
- HCPCS Level II
- Coverage
- Carrier judgment
- BETOS category
- O1G
- Pricing indicator
- 54
- Effective date
- 20241213
Verify before billing. Confirm against current official CMS HCPCS files and your payer's rules before clinical or claims use.